Medicinal chemistry into the millennium /
Saved in:
| Imprint: | Cambridge : Royal Society of Chemistry, 2001. |
|---|---|
| Description: | x, 397 p. : ill. ; 24 cm. |
| Language: | English |
| Series: | Special publication ; no. 264 Special publication (Royal Society of Chemistry (Great Britain)) ; no. 264. |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4489972 |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 4489972 | ||
| 005 | 20031020202500.0 | ||
| 008 | 010326s2001 enka b 000 0 eng | ||
| 003 | ICU | ||
| 015 | |a GBA1-Y3407 | ||
| 020 | |a 0854047697 | ||
| 035 | |a (OCoLC)46651319 | ||
| 040 | |a UKM |c UKM |d OCoLC |d OrLoB-B | ||
| 049 | |a CGUA | ||
| 082 | 0 | 4 | |a 615.19 |2 21 |
| 245 | 0 | 0 | |a Medicinal chemistry into the millennium / |c edited by M.M. Campbell and I.S. Blagbrough. |
| 260 | |a Cambridge : |b Royal Society of Chemistry, |c 2001. | ||
| 300 | |a x, 397 p. : |b ill. ; |c 24 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a Special publication ; |v no. 264 | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | 0 | |t Design of Macrocyclic Peptidase Inhibitors: The Related Roles of Structure-based Approaches and Library Chemistry / |r P. A. Bartlett, N. Yusuff and H.-J. Pyun / |r [et al.] -- |t Merging Rational Drug Design with Combinatorial Chemistry: Reasonable and Unreasonable Expectations / |r D. H. Rich, N. A. Dales and X. Fan / |r [et al.] -- |t The Use of Structural Genomics and Protein Superfamilies in Drug Discovery: Prediction that the Binding Site of the Insulin Receptor Ectodomain Lies at the Concave Face of a [beta]-Helix / |r M. Martin-Martinez, K. Siddle and T. L. Blundell -- |t Ligand-gated Ion Channels as Targets: Problems and Possibilities / |r P. D. Leeson -- |t Structural and Stereochemical Requirements for Activation and Blockade of Excitatory Amino Acid Receptors / |r F. A. Slok, H. Brauner-Osborne and T. B. Stensbol / |r [et al.] -- |t Antagonists Acting at the NMDA Receptor Complex: Potential for Therapeutic Applications / |r D. E. Jane -- |t Recent Advances in Glycine Antagonists as Neuroprotective Agents / |r G. Gaviraghi, R. Di Fabio and D. Donati / |r [et al.] -- |t Bombesin, Tachykinins and Mimetics of Protein-Protein Interactions / |r D. C. Horwell, J. A. H. Lainton and J. A. O'Neill / |r [et al.] -- |t Potent and Selective 5-HT[subscript 6] Receptor Antagonists / |r S. M. Bromidge -- |t Dual D[subscript 2]-Receptor and [beta][subscript 2]-Adrenoceptor Agonists for the Treatment of Airways Diseases / |r F. Ince -- |t Discovery of a Small, Non-peptidyl Mimic of Granulocyte-colony Stimulating Factor / |r J. I. Luengo, S.-S. Tian and P. Lamb / |r [et al.] -- |t EGFR Tyrosine Kinase Inhibitors in the Treatment of Cancer / |r A. J. Barker -- |t The Ineradicable Impact of Irreversible Inhibitors: Can Erbbicide Contribute to the Tumouricide of EGFR-Dependent Cancers? / |r A. J. Bridges, W. A. Denny and E. M. Dobrusin / |r [et al.] -- |t P38 MAP Kinase Inhibitors: Progress, Pitfalls and Possibilities / |r J. L. Adams, T. F. Gallagher and J. C. Boehm / |r [et al.] -- |t Inhibition of T-Cell Tyrosine Kinases / |r P. D. Davis, R. A. Allen and D. A. Berg / |r [et al.] -- |t Gene Regulating Kinases and Their Role in Inflammatory Diseases / |r A. J. Lewis and A. M. Manning -- |t The 6-Hydroxyl Group of Inositol 1-Phosphate Serves as an H-Bond Donor in its Catalytic Hydrolysis by Inositol Monophosphatase: Design and Solid-phase Synthesis of Mechanism Based Inhibitors / |r D. Gani, M. Akhtar and M. Beaton / |r [et al.] -- |t Delta Technology for Protease Inhibition / |r B. A. Katz, R. M. Stroud and J. M. Clark / |r [et al.] -- |t Structure-based Design of Irreversible, Peptidomimetic Human Rhinovirus 3C Protease Inhibitors / |r P. S. Dragovich, S. E. Webber and S. A. Fuhrman / |r [et al.] -- |t Inhibition of the Osteoclast Specific Thiol Protease, Cathepsin K / |r D. F. Veber, R. Marquis and D. S. Yamashita / |r [et al.] -- |t Glycoconjugates as Tumor-associated Antigens and Ligands in Regulatory Processes / |r H. Kunz, B. Liebe and W. Dippold / |r [et al.] -- |t Protein Glycosylation in Immuno- and Neuro-pathology / |r E. F. Hounsell and D. V. Renouf -- |t Bacterial Polysaccharides - Biologically Active Surface Polymers / |r P.-E. Jansson, M. J. Albert and Y. A. Knirel / |r [et al.] -- |t Structure Activity Relationships of Synthetic Heparin-like Oligosaccharides / |r C. M. Dreef-Tromp, J. E. M. Basten and C. A. A. van Boeckel -- |t Glycopeptides: A Link Between Complex Carbohydrates and Glycoproteins / |r P. M. St. Hilaire, M. Meldal and K. Bock -- |t Selective Inhibition of Nitric Oxide Synthases / |r H. Huang, Y. Lee and H. Q. Zhang / |r [et al.] -- |t Absorption and Distribution as Factors in Drug Design / |r D. Smith -- |t Drug Metabolism and the Medicinal Chemist: So What? / |r B. Testa -- |t Rapid Assessment of Drug Metabolism in the Pharmaceutical Discovery Process / |r M. Bertrand, P. Jackson and B. Walther -- |t Modeling the Active Sites of Cytochrome P450s, One of the Most Important Biotransformation Enzymes / |r N. P. E. Vermeulen, M. J. de Groot and J. H. N. Meerman / |r [et al.]. |
| 650 | 0 | |a Clinical chemistry. |0 http://id.loc.gov/authorities/subjects/sh85023014 | |
| 650 | 0 | |a Clinical biochemistry. |0 http://id.loc.gov/authorities/subjects/sh85027062 | |
| 650 | 0 | |a Pharmaceutical chemistry. |0 http://id.loc.gov/authorities/subjects/sh85023026 | |
| 650 | 7 | |a Clinical biochemistry. |2 fast |0 http://id.worldcat.org/fast/fst00864329 | |
| 650 | 7 | |a Clinical chemistry. |2 fast |0 http://id.worldcat.org/fast/fst00864330 | |
| 650 | 7 | |a Pharmaceutical chemistry. |2 fast |0 http://id.worldcat.org/fast/fst01060115 | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 http://id.worldcat.org/fast/fst01423772 | |
| 700 | 1 | |a Campbell, M. M. |1 http://viaf.org/viaf/7318189 | |
| 700 | 1 | |a Blagborough, I. S. | |
| 830 | 0 | |a Special publication (Royal Society of Chemistry (Great Britain)) ; |v no. 264. | |
| 901 | |a ToCBNA |a Analytic | ||
| 903 | |a HeVa | ||
| 903 | |a Hathi | ||
| 929 | |a cat | ||
| 999 | f | f | |i dfd91520-38f0-50cf-a0d2-9b37677feacf |s c7a3391e-bff7-5b0c-ba10-a35d92030785 |
| 928 | |t Library of Congress classification |a QD1.C452 no.264 |l ASR |c ASR-SciASR |i 4518481 | ||
| 927 | |t Library of Congress classification |a QD1.C452 no.264 |l ASR |c ASR-SciASR |g Analytic |e CRERAR |b A57192642 |i 7090005 | ||
